Hurotadine Eye Drops 0.2% (Olopatadine Hydrochloride)
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Huons Co., Ltd.
MFDS item code 202004122 · Approved 2020.05.29
This product's status changed to Approval withdrawn on 2024.03.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Relief of symptoms of allergic conjunctivitis
This medication is used to alleviate symptoms such as itching, redness, and tearing of the eyes caused by allergic conjunctivitis. It helps reduce inflammation of the eyes and relieve discomfort, enabling the patient to lead a more comfortable daily life.
One drop once daily.
This medication should not be used by patients who have an allergic reaction to the active ingredient or components. Symptoms such as headache, taste disturbance, and dizziness may occur during use. There may also be occurrences of punctate keratitis or keratitis, eye pain, dryness, redness, and itching, so caution is needed. Dryness of the nose, rhinitis, dry mouth, contact dermatitis, and fatigue may infrequently occur. Symptoms similar to cold or pharyngitis have been reported in about 10%, and symptoms such as malaise, low back pain, flu-like symptoms, frequent cough, infection, nausea, and sinusitis may also occur. This medication contains phosphate and can rarely lead to corneal calcification in patients with severe corneal damage. Do not use in cases of eye irritation related to contact lenses, and wait at least 15 minutes before wearing contact lenses following application. Vision may be temporarily blurred after instillation, so one should wait until vision returns to normal before driving or operating machinery. This medication is intended for local use in the eyes only and should not be administered orally or intravenously. Care should be taken not to allow the tip of the container to come into direct contact with the eye, and the cap should be securely closed after use to prevent contamination. If used with other eye drops, a minimum interval of 5 minutes should be maintained, and eye ointments should be applied last. Use during pregnancy should be carefully considered for risks and benefits to the fetus, and effects on breastfeeding infants should also be noted. It can be safely used in children over 3 years old and presents no special differences for the elderly. In case of overdose, seek proper observation and treatment at a hospital immediately. This medication can cause discoloration for patients wearing soft contact lenses, so caution is advised.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture ingress, ideally at a cool place between 2 degrees to 25 degrees Celsius. Avoid direct sunlight and high temperatures, and store in a safe place out of reach of children.
An eye drop solution in an opaque white container, filled with a colorless to pale yellow liquid.
3 milliliters / bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Huons Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.